key: cord-0983736-2gwrw2su authors: Nanchal, Rahul; Patel, Dhaval; Guddati, Achuta Kumar; Sakhuja, Ankit; Meersman, Mark; Dalton, Drew; Kumar, Gagan title: Outcomes of Covid 19 patients—Are Hispanics at greater risk? date: 2021-10-26 journal: J Med Virol DOI: 10.1002/jmv.27384 sha: 515bd6214a0de96ee330d6ad1cc4172db5fa8791 doc_id: 983736 cord_uid: 2gwrw2su Disparities in outcomes exist in outcomes of coronavirus disease‐19 (COVID‐19). Little is known about other ethnic minorities in United States. We included all COVID‐19 positive adult patients (≥18 years) hospitalized between March 1, 2020 and February 5th 2021. We compared in hospital mortality, use of intensive care unit services and inflammatory markers between non‐Hispanic whites with non‐White/Black Hispanic. Multivariable Cox proportional Hazard models were used to adjust for differences between the two groups. There were 4059 hospital admissions with COVID‐19 in the study period. Of the 3288 White, 789 (24%) required intensive care unit (ICU) admission in comparison to 187 (24.3%) of the 770 Hispanics. Unadjusted mortality was higher in Whites than Hispanics (17.1% vs. 10.7%; p < 0.001). After adjusting for confounding variables, in‐hospital mortality was not statistically different for Whites in comparison to Hispanics (hazard ratio [HR]: 0.96, 95% confidence interval [CI]: 0.76–1.21, p = 0.73). The adjusted rates of ICU transfers were significantly higher in Hispanics (HR: 1.34, 95% CI: 1.11–1.61, p = 0.002). Hispanics had significantly higher C‐reactive protein, lactate dehydrogenase, and fibrinogen when compared to Whites. Hispanics as compared to Whites with COVID‐19 require higher rates of ICU admission but have a similar mortality. Hispanics as compared to Whites with COVID‐19 require higher rates of ICU admission but have a similar mortality. their white counterparts, little is known about other ethnic minorities in the United States. [12] [13] [14] One plausible biological explanation for these differences is variation of the inflammatory host response by ethnicity. 15, 16 As an example, investigators have reported that the 3p21.31 gene cluster may predispose COVID-19 patients to the development of acute respiratory failure. 17 A surrogate window to the assessment of inflammation is the use of markers such as ferritin, C-reactive protein (CRP) and D-dimers which are both routinely measured at the bedside and have prognostic significance in COVID- 19. 18 The Northeast Georgia Health System serves a large population of non-White Hispanics. We, therefore, sought to compare ethnic differences in clinical characteristics and outcomes amongst non-Hispanic Whites and non-White/Black Hispanics hospitalized with COVID- 19 . We reasoned that the differences would likely be most apparent in the sicker subset of COVID-19 patients and, therefore, also analyzed persons requiring intensive care unit (ICU) admission as a separate cohort. We hypothesized that there would be significant variation in markers of inflammation by ethnicity. We performed a retrospective analysis of prospectively collected data of all adult COVID-19 patients (age ≥18 years) admitted to a large community hospital in a rural setting in Northeast Georgia between March 1st, 2020 and February 5th, 2021. COVID-19 patients were identified using positive PCR COVID testing. We obtained clinical and demographical details of patients from Epic ® Caboodle data warehouse and Cerner APACHE ® Outcomes. Systems integration was provided by IPC Global and we leveraged their in-Process Data Factory innovation running on an AWS ® VPC. The study was reviewed and found exempt by the Northeast Georgia Health System IRB. We included all hospitalized COVID-19 positive adult patients (age 18 years and above) who were either non-Hispanic Whites or non-White/Black Hispanics. We only considered the initial hospitalization for COVID-19, readmissions were excluded from our analysis. Our primary outcome of interest was in hospital mortality. We also compared levels of inflammatory markers (ferritin, CRP, lactate dehydrogenase [LDH], fibrinogen and D-dimer) among the two ethnicities. Additionally, for persons who required ICU admission, we compared rates of mechanical ventilation, vasopressor use and renal replacement therapy which reflect intensity of ICU care. We performed all statistical analysis using STATA MP 16.0 (Stata-Corp.). We describe categorical data using frequency count and percentages. We report means and SD or medians and interquartile ranges for continuous variables as appropriate for their distribution. We used Chi square tests and Wilcoxon Rank tests to compare categorical and continuous variables, respectively. For all analyses we deemed statistical significance a p value <0.05. For the primary outcome of mortality, we performed time to event analysis and used the log rank test for equity of survivor function. Time to event was calculated from date of hospital admission and right censored on February 5th, 2021. We then con- Similarly, we developed multivariable logistic regression models to determine the association of race with likelihood of ICU admission, receipt of mechanical ventilation, vasopressor requirement and acute kidney injury (AKI) requiring hemodialysis. We performed competing risk analysis to reduce effect of patients who died before requiring these outcomes. We also performed linear regression to determine the association of race with inflammatory markers; for these models we log transformed (natural logs) the markers as they were not normally distributed. For D-dimer we used deciles as we were unable to normalize its distribution. There were 4059 hospital admissions with COVID-19 in the study period. Of the 3288 White, 789 (24%) required ICU admission in comparison to 187 (24.3%) of the 770 Hispanics. Whites were significantly older (mean age 70 vs. 51; p < 0.001) than Hispanics. The proportion of males were similar in both groups. Whites had numerically higher rates of obesity, hypertension, congestive heart failure, chronic obstructive pulmonary disease, cirrhosis, venous thromboembolism, and cancer while Hispanics had higher rates of ESRD (Table 1) . During hospitalization Hispanics more often received hydroxychloroquine and tocilizumab while whites received remedesivir and steroids more often. SOFA score on admission were higher in whites, however, markers of inflammation were significantly higher in Hispanics. This included ferritin, CRP, LDH and fibrinogen (Appendix: Tables S1 and S2). D-dimer was higher in whites. The highest level of inflammatory markers during the hospital stay were also significantly higher in Hispanics except for the D-dimer. This difference persisted when different age groups were compared (Appendix : Table S4 ). There was no difference in the proportion of persons requiring ICU admission amongst White or Hispanics. However, Hispanics were significantly younger, and a larger proportion were men ( Table 2) . The adjusted rates of ICU transfers were significantly higher in Hispanics (Appendix: Table S3 ). The adjusted likelihood for use of mechanical ventilation, vasopressor was also higher in Hispanics, though use of mechanical ventilation did not reach significance. Use of hemodialysis for newly diagnosed AKI was not different between the two groups. However, inflammatory markers like CRP, LDH and fibrinogen were significantly higher in Hispanics even after adjusting These may have affected the precision of our estimates. Despite these limitations we show that in a single rural health system in Northeast Georgia Hispanics as compared to Whites with COVID-19 are younger, require higher rates of ICU admission but have a similar mortality. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review Racial and ethnic disparities in COVID-19 incidence by age, sex, and period among persons aged <25 years-16 U.S. Jurisdictions Racial disparities in incidence and outcomes among patients with COVID-19 Disparities in COVID-19 incidence, hospitalizations, and testing, by area-level deprivation-Utah An ecologic study of disparities in COVID-19 incidence and case fatality in Oakland County, MI, USA, during a state-mandated shutdown Actual racial/ethnic disparities in COVID-19 mortality for the non-Hispanic black compared to non-Hispanic White population in 35 US States and their association with structural racism Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: a cross-sectional study The association of race and COVID-19 mortality Association of race with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at 92 US hospitals COVID-19 outcomes, risk factors and associations by race: a comprehensive analysis using electronic health records data in Michigan Medicine Hospitalization and mortality among black patients and white patients with Covid-19 Assessment of COVID-19 hospitalizations by race/ethnicity in 12 States Disparities in incidence of COVID-19 among underrepresented racial/ethnic groups in counties identified as hotspots during Characteristics and outcomes of Hispanic/Latinx patients with coronavirus disease 19 (COVID-19) requiring hospitalization in Rhode Island: a retrospective cohort study A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women Genomewide association study of severe Covid-19 with respiratory failure Association of inflammatory markers with the severity of COVID-19: a meta-analysis Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study Outcomes of Covid 19 patients-Are Hispanics at greater risk?